“…Furthermore, our findings indicate an increasing possibility for equal access and inclusion for diverse populations, home administration of medicine, retention and compliance, and monitoring of trial participants' safety. These findings comply with international literature [1,5,6,[9][10][11][12][13]. However, the literature also raises concerns that DCT can be exclusive to demographic characteristics, such as age, race, socioeconomic status, and rural living with poor internet connection, thereby creating inequity [12].…”